2003
DOI: 10.1038/laban1003-33
|View full text |Cite
|
Sign up to set email alerts
|

Frequently Asked Questions About the Public Health Service Policy on Humane Care and Use of Laboratory Animals

Abstract: The authors answer eight questions commonly asked of the Office of Laboratory Animal Welfare concerning Public Health Service Policy on Humane Care of Use of Laboratory Animals.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2006
2006
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 24 publications
(3 citation statements)
references
References 5 publications
0
3
0
Order By: Relevance
“…committees may only approve, require modification (to secure approval) or withhold approval of a protocol 1,2 . We highly recommend using this unambiguous language when communicating with the principal investigator (PI) 3,4 . the phrase 'approved pending modifications' is confusing, and IAcUcs should avoid using it 4 .…”
Section: A Word From Olaw and Usdamentioning
confidence: 99%
See 1 more Smart Citation
“…committees may only approve, require modification (to secure approval) or withhold approval of a protocol 1,2 . We highly recommend using this unambiguous language when communicating with the principal investigator (PI) 3,4 . the phrase 'approved pending modifications' is confusing, and IAcUcs should avoid using it 4 .…”
Section: A Word From Olaw and Usdamentioning
confidence: 99%
“…We highly recommend using this unambiguous language when communicating with the principal investigator (PI) 3,4 . the phrase 'approved pending modifications' is confusing, and IAcUcs should avoid using it 4 .…”
Section: A Word From Olaw and Usdamentioning
confidence: 99%
“…A change in animal model by the investigator post award is an action that, per the terms and conditions of the GPS, is considered a change in scope and therefore requires prior approval by the relevant GMO of the NIH awarding component (not OLAW). The 1995 OLAW guidance, referenced in two of the scenario responses, concerning criteria in determining what constitutes a "significant change" is in the context of whether IACUC review is required for changes that investigators might potentially make to approved protocols 5 .…”
mentioning
confidence: 99%